Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mastec (MTZ) Asset Writedowns and Impairment: 2010-2025

Historic Asset Writedowns and Impairment for Mastec (MTZ) over the last 3 years, with Mar 2025 value amounting to -$706,000.

  • Mastec's Asset Writedowns and Impairment fell 113.58% to -$706,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$9.2 million, marking a year-over-year decrease of 39.41%. This contributed to the annual value of $3.3 million for FY2019, which is 93.04% down from last year.
  • As of Q1 2025, Mastec's Asset Writedowns and Impairment stood at -$706,000, which was down 113.58% from $5.2 million recorded in Q1 2024.
  • Mastec's 5-year Asset Writedowns and Impairment high stood at $5.2 million for Q1 2024, and its period low was -$706,000 during Q1 2025.
  • For the 3-year period, Mastec's Asset Writedowns and Impairment averaged around $1.7 million, with its median value being $500,000 (2023).
  • Per our database at Business Quant, Mastec's Asset Writedowns and Impairment soared by 940.00% in 2024 and then tumbled by 113.58% in 2025.
  • Quarterly analysis of 3 years shows Mastec's Asset Writedowns and Impairment stood at $500,000 in 2023, then skyrocketed by 940.00% to $5.2 million in 2024, then plummeted by 113.58% to -$706,000 in 2025.
  • Its Asset Writedowns and Impairment stands at -$706,000 for Q1 2025, versus $5.2 million for Q1 2024 and $500,000 for Q1 2023.